Brief: Akili Announces FDA Authorization Of Endeavorotc, The First FDA Clearance Of A Digital Treatment For Adults With Adhd Through A Video Game
18/06/2024 21:59
June 18 (Reuters) - Akili Inc AKLI.O :
* AKILI ANNOUNCES FDA AUTHORIZATION OF ENDEAVOROTC, THE
FIRST FDA
CLEARANCE OF A DIGITAL TREATMENT FOR ADULTS WITH ADHD THROUGH A
VIDEO GAME
Source text for Eikon: ID:nBw9yJkyVa
Further company coverage: AKLI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Akili
See all newsBrief: Akili Announces FDA Authorization Of Endeavorotc, The First FDA Clearance Of A Digital Treatment For Adults With Adhd Through A Video Game
Brief: Virtual Therapeutics, Akili Interactive Enter Into Definitive Merger Agreement To Establish Leading Digital Health Company
Akili Inc reports results for the quarter ended in March - Earnings Summary
Akili Inc expected to post a loss of 14 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Molson Coors, Starbucks, Warner Bros Discovery